Stimulant Use Disorder: A Review of Clinical Effect and Intervention
Dates: July 10, 2026
Meets: F from 9:00 AM to 11:15 AM
Location: Zoom Webinar
Cost: $0.00
There are still openings remaining at this time.
The increasing usage of synthetic stimulants has led to an escalating trend of mortality associated with stimulant use disorders. We will look at the information that the American Society of Addiction Medicine (ASAM) has examined regarding evidence-based strategies and standard of care to assist in improving the quality of care for individuals with Stimulant Use Disorder (StUD). This activity will also review the neurobiology and pharmacology of stimulant use disorders to help provide a greater understanding of the harmful medical and psychiatric consequences. Also, the training will discuss evidence-based and practice-informed strategies to address the challenges and strategies of working with individuals: what to observe and what interventions to apply.
Objectives:
- Discuss the changing epidemiology of stimulant use disorder.
- Review the neurobiology and pathophysiology in the development of stimulant use disorder.
- Describe the pharmacological properties of the stimulant drug class, including the unique properties.
- Recognize the acute and chronic effects of stimulants, including the signs and symptoms of intoxication, overdose, dependence, and withdrawal.
- Describe the most common clinical challenges in treating patients with stimulant use disorder, including management of stimulant-induced psychosis.
- Review the current evidence for pharmacological treatment options for stimulant and methamphetamine use disorders.
Notes:
This event is subject to priority registration. If you have a code, you may register yourself now. If you do not have a registration code, please add yourself to the waitlist. Any registration spots avilable after the priority registration period is over will be awarded on a first-come first-served basis for those on the waitlist.
Certificates for this event are distributed by Hazelden Betty Ford Foundation upon completion of a post-event quiz and evaluation.
If you have any questions about this event, please email learn@midsouth.ualr.edu.
| Fee: | $0.00 |
|---|---|
| Hours: | 2.00 |
Zoom Webinar
Emily Brunner
MD, DFASAM, Physician, TTA Consultant
Dr. Emily Brunner is both certified in family medicine and a distinguished fellow in the field of addiction medicine. She has experience treating addiction in both inpatient and outpatient settings. She is an experienced speaker and specializes in trauma-informed clinical treatment of substance use disorders with a comprehensive and compassionate approach.
Dr. Brunner has been involved in leadership of the Minnesota Society of Addiction Medicine and is now on the national board of the American Society of Addiction Medicine.
